See the DrugPatentWatch profile for nivolumab

Nivolumab Manufacturers Around the World: Beyond the US

Nivolumab, a groundbreaking immunotherapy medication, has revolutionized the treatment of various cancers. Developed by Bristol-Myers Squibb (BMS), nivolumab has been approved by regulatory authorities worldwide. While the US is home to the original manufacturer, BMS, several other countries have their own nivolumab manufacturers. In this article, we'll explore the global landscape of nivolumab manufacturers, highlighting countries beyond the US.

Global Nivolumab Market

The global nivolumab market is expected to grow significantly in the coming years, driven by increasing demand for immunotherapy treatments and expanding patient populations. According to a report by Grand View Research, the global nivolumab market size is projected to reach USD 14.6 billion by 2025, growing at a CAGR of 15.1% during the forecast period.

European Nivolumab Manufacturers

Several European countries have their own nivolumab manufacturers, including:

Germany: Boehringer Ingelheim

Boehringer Ingelheim, a German pharmaceutical company, has partnered with BMS to manufacture and distribute nivolumab in Europe. The company's manufacturing facility in Biberach, Germany, produces the medication under license from BMS.

France: Sanofi

Sanofi, a French multinational pharmaceutical company, has also partnered with BMS to manufacture and distribute nivolumab in Europe. Sanofi's manufacturing facility in Évry, France, produces the medication under license from BMS.

Italy: Menarini

Menarini, an Italian pharmaceutical company, has partnered with BMS to distribute nivolumab in Italy. Menarini's manufacturing facility in Florence, Italy, produces the medication under license from BMS.

Asian Nivolumab Manufacturers

Several Asian countries have their own nivolumab manufacturers, including:

Japan: Ono Pharmaceutical

Ono Pharmaceutical, a Japanese pharmaceutical company, has partnered with BMS to manufacture and distribute nivolumab in Japan. Ono Pharmaceutical's manufacturing facility in Osaka, Japan, produces the medication under license from BMS.

China: Shanghai Fosun Pharmaceutical

Shanghai Fosun Pharmaceutical, a Chinese pharmaceutical company, has partnered with BMS to distribute nivolumab in China. Shanghai Fosun Pharmaceutical's manufacturing facility in Shanghai, China, produces the medication under license from BMS.

Other Countries

Several other countries have their own nivolumab manufacturers, including:

Canada: Apotex

Apotex, a Canadian pharmaceutical company, has partnered with BMS to distribute nivolumab in Canada. Apotex's manufacturing facility in Toronto, Canada, produces the medication under license from BMS.

Australia: Mayne Pharma

Mayne Pharma, an Australian pharmaceutical company, has partnered with BMS to distribute nivolumab in Australia. Mayne Pharma's manufacturing facility in Melbourne, Australia, produces the medication under license from BMS.

Conclusion

In conclusion, while the US is home to the original manufacturer of nivolumab, several other countries have their own nivolumab manufacturers. From Germany to Japan, and from Canada to Australia, the global landscape of nivolumab manufacturers is diverse and complex. As the demand for immunotherapy treatments continues to grow, it's essential to understand the global supply chain of nivolumab and its manufacturers.

Key Takeaways

* Nivolumab is manufactured and distributed by several companies around the world, beyond the US.
* European countries like Germany, France, and Italy have their own nivolumab manufacturers.
* Asian countries like Japan and China have their own nivolumab manufacturers.
* Other countries like Canada and Australia also have their own nivolumab manufacturers.
* The global nivolumab market is expected to grow significantly in the coming years.

FAQs

1. Who is the original manufacturer of nivolumab?
Answer: Bristol-Myers Squibb (BMS).
2. Which European countries have their own nivolumab manufacturers?
Answer: Germany, France, Italy, and others.
3. Which Asian countries have their own nivolumab manufacturers?
Answer: Japan and China.
4. Which Canadian company has partnered with BMS to distribute nivolumab in Canada?
Answer: Apotex.
5. Which Australian company has partnered with BMS to distribute nivolumab in Australia?
Answer: Mayne Pharma.

Sources

1. Grand View Research. (2020). Nivolumab Market Size, Share & Trends Analysis Report by Application (Melanoma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma), by Region, and Segment Forecasts, 2020 - 2025.
2. DrugPatentWatch.com. (n.d.). Nivolumab Patent Expiration.
3. Boehringer Ingelheim. (n.d.). Nivolumab.
4. Sanofi. (n.d.). Nivolumab.
5. Menarini. (n.d.). Nivolumab.
6. Ono Pharmaceutical. (n.d.). Nivolumab.
7. Shanghai Fosun Pharmaceutical. (n.d.). Nivolumab.
8. Apotex. (n.d.). Nivolumab.
9. Mayne Pharma. (n.d.). Nivolumab.